News from NORD

NORD and Neurology Reviews Publish Special Report


 

NORD and Neurology Reviews together have published the third annual Rare Neurological Disease Special Report in print and digital editions to promote awareness and understanding of rare neurological diseases among medical professionals. The publication includes articles on the efficacy of cannabis in treating children with rare and refractory epilepsy, delays in diagnosis and treatment of infantile spasms, telemedicine, new and potential therapies for rare neuromuscular disorders, and the clinical therapeutic potential of gene therapy.

Recommended Reading

Pitolisant Reduces Cataplexy Attacks in Narcolepsy
MDedge Neurology
NORD Awards Grants for Rare Disease Research
MDedge Neurology
NORD Publishes Basic Principles for Health Coverage Reform
MDedge Neurology
NORD Submits Letter to Congress on Pre-Existing Conditions
MDedge Neurology
NORD Unveils “Do Your Share for Rare” Year-Long Awareness Campaign
MDedge Neurology
Tickets Now On Sale for NORD’s 2017 Rare Impact Awards
MDedge Neurology
Anthony Fauci faces the ‘perpetual challenge’ of emerging infections
MDedge Neurology
FDA approves deutetrabenazine for Huntington’s-associated chorea
MDedge Neurology
FDA approves first home genetic health risk test
MDedge Neurology
NORD Announces Recipients of 2017 Rare Impact Awards
MDedge Neurology